Natera, Inc.
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as tw…
Medical - Diagnostics & Research
US, San Carlos [HQ]
Ratios
11 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||
| Gross Margin | 32.44 | 50.78 | 40.72 | 37.54 | 33.82 | 35.55 | 41.96 | 47.92 | 49.09 | 44.37 | 45.52 | |
| Profit Margin | -67.26 | -3.23 | -36.92 | -44.12 | -64.62 | -49.74 | -41.29 | -58.76 | -75.42 | -66.79 | -40.16 | |
| Operating Margin | -45.80 | 0.42 | -31.43 | -44.45 | -63.54 | -44.49 | -43.22 | -55.31 | -74.85 | -65.96 | -40.97 | |
|
EPS Growth
|
- - | 86.14 | -1,814.29 | 30.60 | -37.63 | 13.28 | 19.37 | -58.66 | -83.45 | -6.91 | 32.14 | |
| EPS USD | -101.00 | -14.00 | -268.00 | -186.00 | -256.00 | -222.00 | -179.00 | -284.00 | -521.00 | -557.00 | -378.00 | |
| Return on Assets (ROA) | -62.14 | -4.17 | -26.49 | -45.46 | -76.25 | -47.79 | -21.42 | -24.65 | -38.15 | -39.28 | -29.84 | |
| Return on Equity (ROE) | 21.64 | 3.01 | -38.03 | -89.94 | 1,314.50 | -398.46 | -44.79 | -47.25 | -72.20 | -77.62 | -56.81 | |
| Return on Invested Capital (ROIC) | 22.73 | -0.68 | -22.65 | -61.90 | -119.21 | -73.82 | -30.97 | -28.47 | -44.87 | -47.36 | -38.92 | |
| Solvency | ||||||||||||
| Equity Ratio | -200 | -100 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | 40.70 | 21.69 | 15.87 | 23.55 | 68.90 | 46.06 | 25.76 | 29.37 | 31.66 | 31.45 | 25.73 | |
| Debt/Equity | -14.17 | -15.65 | 22.78 | 46.61 | -1,187.82 | 384.03 | 53.85 | 56.31 | 59.92 | 62.14 | 48.99 | |
| Debt/EBITDA | 27.33 | -1,432.08 | -19.68 | -36.14 | -83.98 | -65.70 | -69.67 | -107.86 | -66.36 | 5.10 | 49.41 | |
|
Debt/Capitalization
|
-16.51 | -18.55 | 18.55 | 31.79 | 109.19 | 79.34 | 35.00 | 36.02 | 37.47 | 38.33 | 32.88 | |
| Long-Term Debt/Capitalization | -15.07 | -16.66 | - - | - - | 116.54 | 69.52 | 26.40 | 31.51 | 34.32 | 33.67 | 26.99 | |
| Interest Debt per Share USD | 0.99 | 0.85 | 1.74 | 0.97 | 2.39 | 2.32 | 2.31 | 3.57 | 4.41 | 4.55 | 3.37 | |
| Debt Growth | - - | 10.31 | 56.97 | 17.90 | 148.22 | 0.27 | 21.51 | 82.44 | 42.99 | 12.03 | 0.78 | |
| Liquidity | ||||||||||||
| Current Ratio | 208.35 | 356.44 | 311.56 | 180.59 | 137.23 | 211.02 | 290.85 | 433.38 | 499.25 | 390.28 | 409.59 | |
| Quick Ratio | 157.53 | 311.72 | 293.75 | 165.44 | 120.48 | 189.59 | 274.83 | 409.86 | 473.32 | 368.02 | 376.62 | |
| Cash Ratio | 129.39 | 291.83 | 35.97 | 15.82 | 11.96 | 40.71 | 34.43 | 24.45 | 38.54 | 150.08 | 208.96 | |
| Operating Cash Flow Ratio | -100 | - - | - - | - - | - - | - - | - - | - - | -100 | -100 | - - | |
| Turnover | ||||||||||||
| Inventory Turnover | 349.93 | 679.22 | 1,394.35 | 2,113.72 | 1,551.41 | 1,218.04 | 1,415.77 | 1,016.52 | 1,183.31 | 1,288.64 | 1,447.12 | |
| Receivables Turnover | 831.89 | 2,680.73 | 3,247.27 | 1,620.44 | 2,556.22 | 414.08 | 566.68 | 497.68 | 512.38 | 335.63 | 389.01 | |
| Payables Turnover | 329.96 | 884.13 | 1,539.08 | 1,181.06 | 1,636.72 | 1,138.38 | 2,039.40 | 2,515.07 | 1,170.40 | 1,464.80 | 3,932.73 | |
|
Asset Turnover
|
92.38 | 128.85 | 71.77 | 103.03 | 117.99 | 96.08 | 51.89 | 41.95 | 50.59 | 58.82 | 74.29 | |
| Fixed Turnover | 563.49 | 1,092.97 | 1,497.68 | 672.28 | 711.02 | 1,058.74 | 643.07 | 714.20 | 502.28 | 499.14 | 645.36 | |
| Coverage | ||||||||||||
| Interest Coverage | -211.62 | 15.76 | -1,707.22 | -18,102.81 | -3,181.27 | -1,094.20 | -1,222.06 | -1,434.01 | -5,637.25 | -5,805.77 | -3,509.78 | |
| Asset Coverage | 100 | 300 | 500 | 300 | 100 | 100 | 300 | 200 | 200 | 200 | 200 | |
| Cash Flow Coverage (CFGR) | -99.28 | 39.12 | -89.88 | -148.92 | -78.58 | -57.15 | -42.27 | -66.66 | -85.63 | -98.39 | -65.86 | |
| EBITDA Coverage | -100 | - - | -1,900 | -17,800 | -3,100 | -1,100 | -1,100 | -1,300 | -5,500 | -5,700 | -3,200 | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | - - | 100 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Market Prospects | ||||||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | -5.62 | -0.78 | -24.83 | -15.90 | -28.44 | -15.90 | -5.33 | -2.85 | -5.58 | -13.86 | -6.04 | |
|
Price/Earnings (P/E)
|
-1,779.43 | -12,817.31 | -402.71 | -629.12 | -351.60 | -628.83 | -1,877.24 | -3,509.23 | -1,792.86 | -721.62 | -1,656.71 | |
| Price/Earnings Growth (PEG) | - - | 148.80 | -0.22 | 20.56 | -9.34 | 47.35 | 96.92 | -59.82 | -21.48 | -104.44 | 51.55 | |
|
Price/Book (P/B)
|
-385.02 | -385.41 | 153.17 | 565.83 | -4,621.74 | 2,505.66 | 840.77 | 1,658.09 | 1,294.53 | 560.13 | 941.22 | |
| Price/Tangible Book (P/TB) | -385.02 | -385.41 | 153.17 | 565.83 | -4,621.74 | 2,505.66 | 840.77 | 1,658.09 | 1,294.53 | 560.13 | 941.22 | |
| Price/Sales (P/S) | 1,196.91 | 414.56 | 148.67 | 277.54 | 227.21 | 312.77 | 775.09 | 2,061.92 | 1,352.10 | 481.95 | 665.40 | |
|
Price/Cash Flow (P/CF)
|
-2,736.40 | 6,295.02 | -748.05 | -815.24 | -495.16 | -1,141.77 | -3,693.51 | -4,417.36 | -2,522.76 | -916.12 | -2,916.89 | |
| Price/Free CF (P/FCF) | -2,039.56 | 123,892.68 | -619.48 | -620.87 | -449.35 | -1,082.27 | -3,425.29 | -3,988.90 | -2,247.67 | -824.93 | -2,517.32 | |
| Price/Operating CF (P/OCF) | -2,736.40 | 6,295.02 | -748.05 | -815.24 | -495.16 | -1,141.77 | -3,693.51 | -4,417.36 | -2,522.76 | -916.12 | -2,916.89 |